Chunping Qiu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 11

Top Topics

Signaling Pathway

Endometrial Cancer

Top Venues

Cell death & disease

Cell death discovery

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tong Wang, Wenxiu Guo, Xiaochen Ren, Fangfang Lang, Ying Ma, Chunping Qiu, Jie Jiang
Progress of immunotherapies in gestational trophoblastic neoplasms. Journal of cancer research and clinical oncology (2023)
Lina Wei, Xiaohong Ma, Yixin Hou, Tianyi Zhao, Rui Sun, Chunping Qiu, Yao Liu, Ziyi Qiu, Zhiming Liu, Jie Jiang
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell death discovery 9 (1) (2023)
Lina Wei, Xiaohong Ma, Yixin Hou, Tianyi Zhao, Rui Sun, Chunping Qiu, Yao Liu, Ziyi Qiu, Zhiming Liu, Jie Jiang
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell death discovery 9 (1) (2023)
Lina Wei, Xiaohong Ma, Yixin Hou, Tianyi Zhao, Rui Sun, Chunping Qiu, Yao Liu, Ziyi Qiu, Zhiming Liu, Jie Jiang
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma. Cell death discovery 9 (1) (2023)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Fangfang Li, Chen Zhao, Yuchao Diao, Zixiang Wang, Jiali Peng, Ning Yang, Chunping Qiu, Beihua Kong, Yingwei Li
MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS. Cell death & disease 13 (6) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Min Xia, Lina Wei, Kui Guo, Rui Sun, Yao Liu, Chunping Qiu, Jie Jiang
ABX-1431 inhibits the development of endometrial adenocarcinoma and reverses progesterone resistance by targeting MGLL. Cell death & disease 13 (12) (2022)
Xiaohong Ma, Tianyi Zhao, Hong Yan, Kui Guo, Zhiming Liu, Lina Wei, Wei Lu, Chunping Qiu, Jie Jiang
Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. Cell death & disease 12 (6) (2021)